FindTrial
Sign In

Effect of Chinese medicines for Huoxue Shugan Bushen on postoperative pregnancy and recurrence in infertility patients with endometriosis

Effect of Chinese medicines for Huoxue Shugan Bushen on postoperative pregnancy and recurrence in infertility patients with endometriosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070138
Enrollment
Unknown
Registered
2023-04-03
Start date
2022-07-29
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

Huoxue Shugan Bushen Chinese medicine group:No
the placebo group:No

Sponsors

Guang’anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1)A total of 101 patients in the TCM group and 101 patients in the placebo group were enrolled in PPS, who were enrolled in Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period. 2)Ability to stabilize visitors.

Exclusion criteria

Exclusion criteria: 1)Patients with uterine fibroids larger than 4cm in diameter, adenomyosis, pelvic tuberculosis, endometrial tuberculosis, intrauterine adhesions, polycystic ovary syndrome, hyperprolactinemia, and thyroid dysfunction were complicated. 2)Have a history of severe drug allergy. 3)The male factor is infertility. 4)Husband and wife separated.

Design outcomes

Primary

MeasureTime frame
The pregnancy rate;The recurrence rate;—

Secondary

MeasureTime frame
Live-birth rate;—

Countries

China

Contacts

Public ContactZHAO Rui-hua

Guang’anmen Hospital, China Academy of Chinese Medical Sciences

rhzh801@126.com13621021092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 16, 2026